Melanocortin 1 Receptor–Targeted α-Particle Therapy for Metastatic Uveal Melanoma

New effective therapies are greatly needed for metastatic uveal melanoma, which has a very poor prognosis with a median survival of less than 1 y. The melanocortin 1 receptor (MC1R) is expressed in 94% of uveal melanoma metastases, and a MC1R-specific ligand (MC1RL) with high affinity and selectivit...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Nucl Med
Glavni autori: Tafreshi, Narges K., Tichacek, Christopher J., Pandya, Darpan N., Doligalski, Michael L., Budzevich, Mikalai M., Kil, HyunJoo, Bhatt, Nikunj B., Kock, Nancy D., Messina, Jane L., Ruiz, Epifanio E., Delva, Nella C., Weaver, Adam, Gibbons, William R., Boulware, David C., Khushalani, Nikhil I., El-Haddad, Ghassan, Triozzi, Pierre L., Moros, Eduardo G., McLaughlin, Mark L., Wadas, Thaddeus J., Morse, David L.
Format: Artigo
Jezik:Inglês
Izdano: Society of Nuclear Medicine 2019
Teme:
Theranostics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6681690/
https://ncbi.nlm.nih.gov/pubmed/30733316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.217240
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items